US$ 26.98
ghk-cu 100mg copper peptide — Research Grade GHK-CU – C2 Peptides
Description
Cagrilintide is an investigational drug not currently approved alone by the FDA

Immune support: aids barrier integrity and white blood cells

The peptide has been shown to reduce oxidative stress markers and reactive oxygen species production in damaged tissues, creating a more favorable environment for regeneration

The contribution of peripheral immune cells to inflammatory demyelination Apart from inflammatory cells from within the CNS, there is evidence that also peripheral immune cells/components might play a role in cuprizone-induced demyelination
